← Back to Search

Artificial Disc Replacement

PerQdisc® Nucleus Replacement Device. for Degenerative Disc Disease

N/A
Waitlist Available
Research Sponsored by Spinal Stabilization Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a small device inserted into the spine to help people with chronic low back pain. The device replaces part of the spinal disc to keep it at its normal height and improve movement, aiming to reduce pain.

Eligible Conditions
  • Degenerative Disc Disease
  • Chronic Lower Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improvement in back pain as measured by 10-centimeter Visual Analog Scale (VAS)
Improvement in degree of disability as measured by the Oswestry Disability Index (ODI)
MRI assessment of the endplate Modic changes.
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nucleus ReplacementExperimental Treatment1 Intervention
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.

Find a Location

Who is running the clinical trial?

Spinal Stabilization TechnologiesLead Sponsor
4 Previous Clinical Trials
203 Total Patients Enrolled
Michael Hess, MDStudy ChairLondon Spine Clinic/ATOS-Klinik
3 Previous Clinical Trials
153 Total Patients Enrolled
~1 spots leftby Dec 2025